Proc Natl Acad Sci U S A (2007) 104(7):246570
This eligibility applies across all PlexusDx treatment options, including semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, tirzepatide injections, and oral formulations
A metabolite of alpha-lipoic acid may trigger autoantibodies against insulin, leading to high concentrations of total serum immunoreactive insulin and causing spontaneous episodes of fasting hypoglycemia (dangerously low blood sugar)
Guilherme Rizzoto, Ghent University, Belgium
First-generation incumbents, such as Wegovy or Zepbound, may benefit from a first-mover advantage building on a large body of evidence, HCPs extensive hands-on experience and possibly brand loyalty, especially from patients in out-of-pocket market segments